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Randomised controlled trials (RCTs) are the best way to 
evaluate the effectiveness and safety of healthcare interven-
tions, although around half of trials fail to recruit to time 
and target, causing delays and increased costs (McDonald 
et al., 2006; Treweek et al., 2018c). Poor recruitment can 
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Abstract
Objective: To compare two methods of providing information about the Bone Anchored Maxillary Protraction (BAMP) 
trial: standard printed information and multimedia websites, for their quality and ease of understanding, and impact on 
decision-making.
Design: Randomised controlled trial.
Setting: Orthodontic outpatient clinic in the UK.
Methods: Participants were 109 adolescents (aged 11–14 years) attending for orthodontic treatment. While awaiting 
treatment they were asked to imagine being recruited to the BAMP clinical trial. They were individually randomised to 
receive the printed or the multimedia website information (comprising text, animations and ‘talking head’ videos). After 
reading or viewing the information, they completed a 9-item Likert scale Decision-Making Questionnaire (DMQ) (score 
range 0–36) plus three free-text questions on their evaluation of the information.
Results: A total of 104 participants completed the questionnaire. Mean total DMQ scores were higher (more positive) in 
the website group (28.1 vs. 27.0), although the difference was small and not statistically significant (P = 0.20). Analysis of 
individual questionnaire items showed two statistically significant differences: the website information had higher ratings on 
‘easy to understand’ (Z = 3.03; P = 0.003) and ‘confidence in decision-making’ (Z = 2.00; P = 0.044). On the three free-
text questions, more positive and fewer negative comments were made about the websites than the printed information.
Conclusion: In this hypothetical trial setting, adolescent patients found that trial information conveyed on a multimedia 
website was easier to understand and made them more confident in their decision about trial participation. Their subjective 
evaluations of the website were also more positive and less negative than about the printed information. Multimedia informa-
tion has the potential to increase the quality of engagement and information exchange when seeking consent for research.
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lead to underpowered and inconclusive trials (Treweek 
et al., 2018c).
Potential trial participants must be provided with infor-
mation, allowing them to make an informed decision on 
participation, and a recent ‘review of reviews’ reported that 
participant information can both facilitate and impede 
recruitment (Sheridan et al., 2020a). The information 
should provide a thorough understanding of what the 
research entails. However, printed trial information has 
been criticised repeatedly as being too long and technical, 
hard to navigate and not engaging (Caldwell et al., 2012; 
Eder et al., 2007).
These problems may be magnified in trials involving 
children or adolescents, who should have an opportunity to 
understand what the research entails and, when appropriate, 
participate in decision-making (Nuffield Council on 
Bioethics, 2015). However, it may be more difficult for 
them to understand relevant concepts and terms, or the 
implications of participation (Barfield and Church, 2005; 
Simon et al., 2004; Stryker et al., 2005; Tait et al., 2015a). 
In particular, children and young people may struggle to 
understand procedures and risks (Hunfeld and Passchier, 
2012).
Depending on the young person’s age and maturity, and 
the family dynamics, decisions on trial participation may 
follow discussion with their family; this may increase the 
negative effects of difficult or unclear information. A recent 
review highlighted the importance of providing research 
information to children and adolescents directly, not just 
via parents, and stressed that it should be both ‘appealing 
and understandable’ (Crane and Broome, 2017). However, 
it is important that this information, used to inform consent 
or assent decisions, should not be marketing, nor prioritise 
entertainment at the expense of its information function.
The UK Health Research Authority recently recom-
mended exploration of the use of non-print media for 
potential research participants (Health Research Authority, 
2016). A novel approach is to use multimedia information, 
whether as a website or offline, allowing written informa-
tion to be replaced by, or presented alongside, animations, 
videos, audio and infographics. Multimedia information 
may increase comprehension of medical information com-
pared with traditional paper-based formats (Hermann, 
2002; Hopper et al., 1994; Tait et al., 2009c, 2012b), poten-
tially through enhanced choice and flexibility, increased 
engagement, and allowing the user to access information 
content in a non-linear way. Several studies suggest that 
multimedia websites can help to inform and recruit poten-
tial research participants (Hutchison et al., 2007; Tait et al., 
2015a; Tait and Voepel-Lewis, 2015d) although none of 
these studies included children or adolescents. In part, mul-
timedia websites offer great potential as a platform for 
mandated health communication because people are 
increasingly familiar with obtaining health and other infor-
mation digitally (Antoniou et al., 2011; Shneerson et al., 
2012). However, it is not clear that everyone prefers digital 
or online information; some may prefer traditional printed 
materials. Furthermore, access to digital information and 
technology is not universal, and unequal access may com-
pound existing income-related health inequalities (Office 
for National Statistics, 2019). In addition, a recent system-
atic scoping review highlighted important concerns that 
children and adolescents have about digital health technol-
ogies, including privacy and trustworthiness (Blower et al., 
2020).
The TRECA (TRials Engagement in Children and 
Adolescents) study is evaluating the effectiveness of multi-
media websites compared to printed information, when 
recruiting children and adolescents to trials (Martin-Kerry 
et al., 2017). This is being undertaken through a linked 
series of studies within a trial (SWATs), to compare the 
effects of two information formats (the REC-approved 
printed information sheets for participants [ISPs], and mul-
timedia websites [MMIs]) on patient recruitment and deci-
sion-making (Rick et al., 2014; Treweek et al., 2018a, 
2018b, 2018c). One of the included SWATs is the bone 
anchored maxillary protraction (BAMP) trial (Mandall, 
2014).
After the small BAMP trial and its linked SWAT had 
closed to recruitment, there was an opportunity to evaluate 
the two forms of trial information with a larger number of 
adolescents awaiting orthodontic treatment, who were not 
being recruited to the BAMP trial itself. During this pro-
cess, we asked them to imagine being asked to take part in 
the BAMP clinical trial. The aim of the present study was to 
compare the multimedia websites and printed information 




The study used a two-arm, parallel-group, individually ran-
domised controlled trial design. Participants were asked to 
imagine being approached about participation in the BAMP 
trial of orthodontic treatment (Mandall, 2014).
Participants were randomised to receive a printed par-
ticipant information sheet (ISP) or view the multimedia 
website (MMI). The allocation sequence was generated by 
the TRECA team at the University of York, using block 
sizes of six allocations and a random number generator 
(Sealed envelope, 2019). The allocations were provided to 
the recruitment site in sequential sealed opaque envelopes.
Study participants
Participants were patients aged 11–14 years and attending 
the orthodontic clinic for routine appointments at Tameside 
and Glossop NHS Trust in the UK.
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Interventions
The printed ISP was the standard participant information 
sheet used in the BAMP trial, which had been approved by 
NHS Research Ethics Committee and comprised 2276 
words across seven printed A4 pages (see Supplementary 
data). The ISP text addressed the patient (e.g. ‘your treat-
ment’ rather than ‘their treatment’).
The multimedia website (MMI) for the BAMP trial, 
which was viewed on a tablet computer, had been devel-
oped by the TRECA research team and Morph, a website 
creation company. It contained all the ISP written con-
tent, with the text amended to improve clarification when 
required. The website text addressed the patient (e.g. 
‘your treatment’ rather than ‘their treatment’). The web-
site also included five short animation videos, each last-
ing 45–60 s (‘Summary of the key aspects of the BAMP 
trial’; ‘Why do we do trials?’; ‘What are trials?’; ‘Who’s 
in a trial team’; ‘Assent and consent’), and 17 short sin-
gle-person ‘talking head’ videos, featuring three individ-
uals (10 with the trial principal investigator, four with an 
adolescent who had received bone anchored maxillary 
protraction, three with a parent of a child who had 
received bone anchored maxillary protraction), each last-
ing 15–50 s and describing different aspects of the trial 
and clinical procedures. The website content was organ-
ised on six main webpages with the following headings: 
‘Home page (including summary animation)’; ‘About the 
trial’; ‘Taking part’; ‘After the trial’; ‘Questions’; and 
‘Contacts’ (see Morph (2020) for the link to examples of 
BAMP MMI content).
The TRECA study websites drew on extensive under-
pinning qualitative research (Martin-Kerry et al., 2019) and 
user testing (Sheridan et al., 2019), and were informed by 
principles of Plain English and information design (Knapp 
et al., 2011), as well as age-appropriateness and readability 
formulae (Readabilityformulas.com). The TRECA Patient 
and Public Involvement Group commented on the content 
and design of the websites throughout their development 
(Sheridan et al., 2020b).
Procedure
Adolescents attending for treatment were asked by the 
orthodontist to take part in the study while they were 
seated in the waiting area. After giving written assent 
(counter-signed by a parent), they were randomly allo-
cated to receive either the printed information or the web-
site presented on a tablet computer. Participants had as 
long as they needed to read or view the information, usu-
ally 15–20 min, after which they were given a printed 
Decision-Making Questionnaire (DMQ), which they 
completed immediately after accessing the trial informa-
tion. Parents attending with the adolescent patient could 
also read or view the information (as preferred), and also 
complete the DMQ with them.
Outcome measure
The primary outcome of this trial was the total score derived 
from the nine-item decision-making questionnaire (DMQ) 
(Table 1), which asked respondents to rate different aspects 
of the information and its impact on decisions. On the first 
item, respondents evaluated ease of understanding (with 
five response choices ranging from ‘very hard’ to ‘very 
easy’); on the other eight items, they were asked to state 
their level of agreement with statements about the informa-
tion (with five response choices ranging from ‘not at all’ to 
‘yes, completely’). Each of the nine Likert scale items was 
scored 0–4, deriving a maximum scale score of 36. A higher 
DMQ score indicates better quality of decision-making. 
The DMQ comprised items evaluating aspects of trial par-
ticipation decision-making indicated as important in the 
underpinning empirical work (Martin-Kerry et al., 2017, 
2019; Sheridan et al., 2019, 2020b), including items on: 
information content; the experience of participation; uncer-
tainty in trials; participation advantages and disadvantages; 
the process of decision-making; and decisional confidence. 
The nine scale items were followed by three free-text ques-
tions that asked respondents: to suggest any additional 
information they would have wanted; to identify aspects 
that were explained well; and for any other comments.
Secondary outcomes were the nine individual question-
naire item scores, and the free-text responses to three ques-
tions, including the frequency of positive and negative 
comments about the information.
Masking
Participants could not be masked to allocation, as they were 
aware of the information format they received. However, 
they had no access to the printed or website information 
that they had not been allocated to receive. The recruiting 
researchers could not be masked to the trial allocation but 
had no influence on participants’ responses.
Sample size
We estimated that a sample size of 109 would give 90% 
power (alpha 0.05) to detect a statistically significant dif-
ference between the groups. This allowed for 10% of par-
ticipants not completing the questionnaires. We assumed 
that a mean between-groups difference of 4.5 on the total 
score (reflecting a mean of 0.5-point difference on each of 
the nine Likert questions) would be meaningful, and esti-
mated that the standard deviation (SD) of the pooled scores 
would be 6.75 (assuming that 95% scores would fall in the 
range of 4.5–31.5).
Statistical and free-text question analyses
Analyses were conducted using Stata v16 (StataCorp, 
2019) on an intention-to-treat basis, using two-sided tests at 
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the 5% significance level. When two adjacent scores for a 
questionnaire item were given by the participants, the lower 
score was included. Up to three missing values on items 
1–9 were allowed per participant, with a total score calcu-
lated by replacing the missing values with the mean score 
from the completed responses given by the participant.
Total DMQ scores were compared between the ISP 
and MMI groups using a linear regression, where total 
DMQ score was the dependent variable and TRECA allo-
cation and gender were independent variables. A sensitiv-
ity analysis was conducted in which the analysis was 
repeated including only participants that had responses to 
all nine DMQ questions. Adjusted mean differences 
(AMDs) are presented alongside 95% confidence inter-
vals (CIs) and P values. Model assumptions were 
checked.
Table 1. Decision-Making Questionnaire item responses, by trial allocation.
Very hard Hard OK Easy Very easy Missing
1.  The information I saw about 
the BAMP trial was easy to 
understand.
MMI 0 (0.0) 1 (1.9) 8 (14.8) 30 (55.6) 13 (24.1) 2 (3.7)
ISP 0 (0.0) 2 (3.6) 20 (36.4) 25 (45.5) 5 (9.1) 3 (5.5)
Overall 0 (0.0) 3 (2.8) 28 (25.7) 55 (50.5) 18 (16.5) 5 (4.6)
 Not at all Not really Not sure Yes, mostly
Yes, 
completely Missing
2.  After seeing the information 
about the BAMP trial I knew 
what taking part would be like.
MMI 0 (0.0) 0 (0.0) 7 (13.0) 30 (55.6) 15 (27.8) 2 (3.7)
ISP 0 (0.0) 1 (1.8) 8 (14.6) 27 (49.1) 16 (29.1) 3 (5.5)
Overall 0 (0.0) 1 (0.9) 15 (13.8) 57 (52.3) 31 (28.4) 5 (4.6)
3.  The information helped me 
understand how my treatment 
or care might change if I took 
part in the BAMP trial.
MMI 0 (0.0) 2 (3.7) 5 (9.3) 31 (57.4) 14 (25.9) 2 (3.7)
ISP 0 (0.0) 3 (5.5) 4 (7.3) 33 (60.0) 11 (20.0) 4 (7.3)
Overall 0 (0.0) 5 (4.6) 9 (8.3) 64 (58.7) 25 (22.9) 6 (5.5)
4.  The possible benefits of taking 
part in the BAMP trial were 
made clear in the information.
MMI 0 (0.0) 1 (1.9) 9 (16.7) 19 (35.2) 23 (42.6) 2 (3.7)
ISP 0 (0.0) 2 (3.6) 4 (7.3) 29 (52.7) 17 (30.9) 3 (5.5)
Overall 0 (0.0) 3 (2.8) 13 (11.9) 48 (44.0) 40 (36.7) 5 (4.6)
5.  The possible disadvantages 
of taking part in the BAMP 
trial were made clear in the 
information.
MMI 0 (0.0) 5 (9.3) 6 (11.1) 20 (37.0) 21 (38.9) 2 (3.7)
ISP 0 (0.0) 2 (3.6) 11 (20.0) 24 (43.6) 15 (27.3) 3 (5.5)
Overall 0 (0.0) 7 (6.4) 17 (15.6) 44 (40.4) 36 (33.0) 5 (4.6)
6.  The information about the 
BAMP trial helped me discuss 
the trial with the person who 
asked me to take part (usually 
a doctor, nurse or researcher).
MMI 1 (1.9) 4 (7.4) 10 (18.5) 23 (42.6) 14 (25.9) 2 (3.7)
ISP 0 (0.0) 0 (0.0) 12 (21.8) 31 (56.4) 9 (16.4) 3 (5.5)
Overall 1 (0.9) 4 (3.7) 22 (20.2) 54 (49.5) 23 (21.1) 5 (4.6)
7.  The information about the 
BAMP trial helped me discuss 
taking part with my parent(s) 
or family.
MMI 1 (1.9) 1 (1.9) 6 (11.1) 32 (59.3) 12 (22.2) 2 (3.7)
ISP 0 (0.0) 1 (1.8) 12 (21.8) 26 (47.3) 13 (23.6) 3 (5.5)
Overall 1 (0.9) 2 (1.8) 18 (16.5) 58 (53.2) 25 (22.9) 5 (4.6)
8.  I am confident that I have 
made the right decision about 
whether or not to take part in 
the BAMP trial.
MMI 0 (0.0) 3 (5.6) 4 (7.4) 22 (40.7) 23 (42.6) 2 (3.7)
ISP 1 (1.8) 0 (0.0) 11 (20.0) 27 (49.1) 13 (23.6) 3 (5.5)
Overall 1 (0.9) 3 (2.8) 15 (13.8) 49 (45.0) 36 (33.0) 5 (4.6)
9.  In all, the information about 
the BAMP trial helped me 
make my decision about 
whether or not to take part.
MMI 0 (0.0) 1 (1.9) 5 (9.3) 24 (44.4) 22 (40.7) 2 (3.7)
ISP 0 (0.0) 0 (0.0) 7 (12.7) 31 (56.4) 14 (25.5) 3 (5.5)
Overall 0 (0.0) 1 (0.9) 12 (11.0) 55 (50.5) 36 (33.0) 5 (4.6)
Values are given as n (%).
BAMP, bone anchored maxillary protraction; ISP, participant information sheet; MMI, multimedia website.
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Further analyses were conducted to assess the differ-
ences in scores on each question between the two groups. 
Scores were compared using Wilcoxon Mann–Whitney 
tests (medians, interquartile ranges [IQRs], z-statistics and 
P values are presented). There is an increased risk of Type 
I error due to multiple testing.
Answers to the free-text questions were analysed statis-
tically (according to the number of respondents making 
positive or negative evaluations of the information) and 
descriptively (using a basic content analysis). An odds ratio 
comparing the number of positive responses between the 
two groups is presented alongside a 95% CI and P value.
Questionnaire data were inputted by one researcher and 
a random 10% data check was undertaken by a second 
researcher.
Ethical approval
Research ethics approval for this study was received from 
the Yorkshire & the Humber – Bradford Leeds Research 
Ethics Committee (17/YH/0082) and the Health Research 
Authority (IRAS ID 212761). This study is also registered 
with the Northern Ireland Hub for Trials Methodology 
Research SWAT Repository (SWAT 97) (Martin-Kerry 
et al., 2017).
Results
A total of 109 participants were randomised, of whom 55 
received the ISP and 54 received the MMI resources. 
Participants were randomised between 25 June 2019 and 17 
March 2020.
Five participants (4.6%) did not complete any questions 
on the DMQ scale and could not be included in analyses 
(Figure 1). The median (IQR) age for all 109 participants 
was 13 years (2). The median (IQR) age was 13 years (2) in 
both the MMI and ISP groups. Overall, 54 (49.5%) of the 
participants were male. There were 29 boys (52.7%) in the 
ISP group and 25 boys (46.4%) in the MMI group.
In the ISP group, 47 participants completed the DMQ 
alone, and three completed it with a parent or carer (two did 
not give an answer). In the MMI group, 50 participants 
completed it alone, whereas two completed it with a parent 
or carer. Summaries of responses to each question in the 
DMQ scale, broken down by TRECA arm, are given in 
Table 1. Missing data totals include the five participants 
who did not complete any of the questionnaire.
Figure 1. Trial CONSORT diagram.
Figure 2. Box plot of total scores on the Decision-Making 
Questionnaire scale.
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Of the 104 participants who completed the DMQ scale, 
there was only one missing response on items 1–9, and only 
one response when a participant had circled two adjacent 
response options. Hence total scores could be calculated for 
all 104 participants. The overall mean score was 27.5 ±4.3. 
The mean total scores were higher in the MMI group (28.1 
± 4.2) than in the ISP group (27.0 ± 4.3). The total scores 
are shown in Figure 2.
The linear regression showed no evidence of a differ-
ence between the two groups: AMD 0.99 (95% CI = –0.66 
to 2.64; P = 0.24). The sensitivity analysis yielded a simi-
lar result: AMD 1.06 (95% CI = –0.63 to 2.74; P = 0.22).
Secondary outcomes
Individual questions. Comparisons of the item scores from 
the two trial groups found statistically significant differ-
ences on two of the nine items: ‘The information I saw 
about the BAMP trial was easy to understand’ (Z = −3.03; 
P = 0.003); and ‘I am confident that I have made the right 
decision about whether or not to take part in the BAMP 
trial’ (Z = −2.00; P = 0.044), both favouring the multime-
dia information. Among participants who viewed the web-
site, 79.7% rated it as ‘very easy’ or ‘easy’, compared to 
54.6% of those allocated to the printed information. ‘Very 
easy’ ratings were given by 24.1% and 9.1%, respectively. 
On whether they were confident in their decision-making, 
83.3% of those in the website group stated ‘yes, com-
pletely’ or ‘yes, mostly’, compared to 72.7% in the printed 
information group. The differences between the groups on 
the other seven items were not statistically significant. 
Results are given in Tables 1 and 2.
Free-text responses. Of the 104 respondents, 63 (60.6%) 
made at least one positive comment about the information 
(34 in the MMI group, 29 in the ISP group). The difference 
between groups was not statistically significant (odds ratio 
[OR] = 1.50; 95% CI = 0.68–3.30; P = 0.32). Three 
respondents made negative comments about the informa-
tion (one in the MMI group and two in the ISP group).
In answer to question 10, ‘Was there anything you 
wanted to know about the BAMP trial but which wasn’t 
included in the information you saw?’, 15 participants 
(14.4%) replied ‘yes’ (eight in the MMI group, seven in the 
ISP group), although 17 participants provided responses 
(nine MMI, eight ISP) (Table 3; Supplementary data). In 
the ISP group, six respondents would have liked more 
information on a variety of aspects, including three who 
Table 2. Exploratory analysis of each question in the Decision-Making Questionnaire.
Question Allocation N Median (IQR) Z-statistic P value
Q1 The information I saw about the BAMP trial was easy to 
understand.
ISP 52 3 (1) −3.03 0.002
MMI 52 3 (0.5)
Q2 After seeing the information about the BAMP trial I knew 
what taking part would be like.
ISP 52 3 (1) −0.13 0.940
MMI 52 3 (1)
Q3 The information helped me understand how my treatment 
or care might change if I took part in the BAMP trial.
ISP 51 3 (0) −0.52 0.601
MMI 52 3 (1)
Q4 The possible benefits of taking part in the BAMP trial were 
made clear in the information.
ISP 52 3 (1) −0.53 0.602
MMI 52 3 (1)
Q5 The possible disadvantages of taking part in the BAMP trial 
were made clear in the information.
ISP 52 3 (1.5) −0.92 0.362
MMI 52 3 (1)
Q6 The information about the BAMP trial helped me discuss 
the trial with the person who asked me to take part (usually a 
doctor, nurse or researcher).
ISP 52 3 (0) −0.04 0.981
MMI 52 3 (2)
Q7 The information about the BAMP trial helped me discuss 
taking part with my parent(s) or family.
ISP 52 3 (1) −0.50 0.647
MMI 52 3 (0)
Q8 I am confident that I have made the right decision about 
whether or not to take part in the BAMP trial.
ISP 52 3 (0.5) −2.00 0.044
MMI 52 3 (1)
Q9 In all, the information about the BAMP trial helped me make 
my decision about whether or not to take part.
ISP 52 3 (1) −1.41 0.160
MMI 52 3 (1)
BAMP, bone anchored maxillary protraction; ISP, participant information sheet; MMI, multimedia website.
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wanted to know more about possible harms of treatment. 
One would have liked the inclusion of images to aid under-
standing. In the MMI group, the responses were similarly 
varied.
To question 11, ‘Can you tell us which aspect(s) about 
BAMP was explained well in the information you saw?’ 64 
participants (61.5%) responded: 34 in the MMI group and 
30 in the ISP group. Responses were highly varied. In the 
ISP group, five participants mentioned the benefits and dis-
advantages of the surgery, while another three mentioned 
its potential benefits. Five participants commented on the 
description of the process; that is, what would happen. One 
made a very negative comment about the ISP (‘It is a lot of 
writing and not attractive to read and it is boring’). In the 
MMI group, 12 participants mentioned the description of 
the process, while four mentioned the advantages and dis-
advantages. Five participants mentioned the videos as 
being helpful, and one praised the MMI ‘interface’.
To question 12 (‘any other comments?’), there were two 
responses in the ISP group (both negative: ‘I think it isn’t 
very attractive’; ‘As a mother I feel this is a lot of informa-
tion for his age group’) and there were eight responses in 
the MMI group, of which six made positive comments (‘the 
information was explained clearly. . .’; ‘very understanda-
ble. . .’; ‘helps me understand the BAMP trial’; ‘the vod-
cast / cartoons were useful’; ‘easy to navigate and 
understand’; ‘helpful when trying to understand how the 
trial helps’), with one negative comment (‘the main reason 
of the trial was hard to understand’) and one question.
Discussion
The DMQs were completed by more than 95% participants 
and evaluations of the information were mostly positive in 
both groups. The mean scale score was higher in the MMI 
group, but the difference was small and not statistically sig-
nificant. Participants in the MMI group were also more 
likely to rate the information as ‘easy to understand’ and 
more likely to state confidence in their decision-making. In 
the free-text responses, more positive and fewer negative 
comments were made about the multimedia than the printed 
information.
The trial had good methodological qualities: random 
and concealed allocation, as well as good completion rates 
for the outcome variables. However, its sample size was 
small, resulting in high levels of variance. Participants were 
adolescents in the target age range of the actual BAMP 
trial, although they were making judgements about a trial 
that was, for them, hypothetical; it may have been difficult 
for such young participants to imagine themselves in this 
situation, which would reduce data validity We could have 
designed the trial so that participants viewed both formats 
of information (printed and multimedia), to draw direct 
comparisons; this may have produced more critical, dis-
cerning evaluations. However, participants were viewing 
the information while awaiting treatment and so had lim-
ited time. We did not evaluate information retention, nor 
did we observe or evaluate participants’ use of the 
information.
The use of multimedia information for trial recruitment 
remains in its infancy, and there has been relatively little 
evaluation of this innovative format of delivery; this is 
especially the case for trials recruiting child or adolescent 
participants. For example, a systematic review of 20 trials 
of multimedia information to inform research consent deci-
sions included 10 in which multimedia resulted in better 
comprehension of the research than printed information 
(Palmer et al., 2012). Furthermore, in six trials there was 
evidence of enhanced information retention from multime-
dia. Notably none of these trials involved children or ado-
lescents. However, in other primary data studies involving 
children or adolescents, multimedia was more effective 
than print in three studies (Carr et al., 2012; O’Lonergan 
and Foster-Harwood, 2011; Tait et al., 2012b) but no more 
effective in one (Shani et al., 2003).
Multimedia to inform patients about healthcare inter-
ventions has been evaluated in a number of settings, and 
four systematic reviews report benefits, when compared to 
printed or spoken information: on patient knowledge, con-
dition self-management, satisfaction with care, as well as 
some clinical outcomes including pain and anxiety 
(Ciciriello et al., 2013; Dahodwala et al., 2018; Dekkers 
et al., 2018; Knox et al., 2019; Tuong et al., 2014). However 
few of the included primary studies involved child or ado-
lescent patients, and none has involved orthodontics or 
dentistry. In child or adolescent populations, there has been 
more evaluation of video animations (which were a compo-
nent of the TRECA MMI). For example, in children with 
epilepsy the provision of animated video information had 
positive impacts on knowledge and medicine adherence, 
and in studies involving children with respiratory condi-
tions animations had positive impacts on use of medication 
delivery devices (Fremont et al., 2018; Indradat et al., 2014; 
Saengow et al., 2018).
The results of this small trial, using a hypothetical sce-
nario, show that multimedia information (such as a web-
site) can provide information to potential trial participants 
at least as well as printed information, and it may improve 
ease of understanding, decisional confidence and other sub-
jective evaluations. This is consistent with studies of chil-
dren’s and adolescents’ use of health technologies, which 
have emphasised the crucial importance of the included 
language (Garrido et al., 2019). Participants’ evaluations of 
the MMI were mostly positive. It was notable that no con-
cerns were expressed about privacy and confidentiality 
associated with the online information, as these concerns 
have been prominent in other research (Blower et al., 2020). 
However, this was a hypothetical study setting for these 
participants and the MMI did not require users to input per-
sonal information.
8 Journal of Orthodontics 
Multimedia offers a choice of information format to 
users and potentially allows them to more easily and pref-
erentially access content that is important to their decisions 
on research participation or healthcare. Enhanced interest 
and engagement can lead to improved understanding and 
retention. However, there remains a lack of research with 
children and adolescents, whose preferences and needs 
may be different to adults. Furthermore, reporting of 
research in this area is often less helpful than it might be: 
what comprises ‘multimedia’ varies greatly among studies 
(in particular historically) although its description in publi-
cation is often brief (Ciciriello et al., 2013; Dahodwala 
et al., 2018; Dekkers et al., 2018; Knox et al., 2019; Palmer 
et al., 2012; Tuong et al., 2014).
The multimedia resources in the TRECA study are cur-
rently being evaluated in six recruitment SWATs (Martin-
Kerry et al., 2017), which will indicate their effects on 
quality of decision-making and actual trial participation 
rates. Multimedia offers great promise in the delivery of 
information in this setting, but careful development, evalu-
ation and reporting are crucial to ensure that resources are 
suitable and useful.
Conclusion
Adolescent orthodontic patients found hypothetical trial 
information conveyed on a website easier to understand 
and they also had more confidence in their decision-mak-
ing, compared to those who read printed information. The 
website information also received more positive and fewer 
negative evaluations.
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